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1. Introduction 
A critical factor in the host immune response to invading pathogens, such as viral infections, is 
the recruitment and infiltration of immune cells to infected tissues. Although the goal of the 
recruited leukocytes is to eliminate the invading pathogens, collateral tissue damage may be 
induced in the process, and, in certain circumstances, may pose a serious threat to the survival 
of the host. The central nervous system (CNS) is a unique site with limited regenerative 
potential and therefore a low threshold for inflammation-induced tissue damage. However, as 
the CNS may become the target of life-threatening viral infections, it is imperative that 
immunological surveillance and efficient effector responses occur in this organ to aid in 
pathogen clearance. Although traditionally characterized as a site of “immune privilege,” 
evidence suggests that immune surveillance and antiviral immunity does occur in the CNS 
(Carson et al., 2006). Understanding how the local inflammatory response within the CNS is 
regulated is a key to understanding the pathogenesis of viral infections in the CNS and 
developing therapies that promote protective and limit pathogenic responses.  
Leukocyte recruitment to any organ site is generally a complex, multistep process. Under 
normal conditions, leukocyte migration into the CNS is maintained at low levels (Hickey, 
2001). During virus-induced inflammation, however, the extravasation of leukocytes is 
increased and targeted to specific compartments of the CNS depending on the inflammatory 
stimulus and the infected region. Chemokines and chemokine receptors have been 
identified as pivotal players in regulating immune cell trafficking into the CNS. Chemokines 
consist of a large family of small, structurally related, chemotactic cytokines that are 
involved in regulating the normal lymphocytic traffic to both the lymphoid and 
nonlymphoid organs and leukocyte emigration into sites of injury and infection (Rossi & 
Zlotnik, 2000). Chemokines select leukocytes for tissue entry based on their expression of 
chemokine receptors, G-protein-coupled cell surface receptors, which have a characteristic 
seven transmembrane structure (Premack & Schall, 1996). In addition to targeting distinct 
leukocyte populations during inflammation, chemokines and their receptors have emerged 
as crucial mediators of a variety of biological processes including development and tissue 
homeostasis. With regard to virus-induced inflammation in the CNS, chemokines and 
chemokine receptors are in a strategic position to coordinate immune responses through 
both the regulation of leukocyte extravasation and also in the final positioning and 
activation of infiltrating cells. 
Immune surveillance of the CNS and the effector function of infiltrating leukocytes into the 
CNS dictate the host-pathogen relationship during viral pathogenesis of the CNS. The 
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challenge of viral pathogenesis research in the CNS has been to define how immune cells 
traffic in and out of the CNS to recognize foreign antigen and their effect on the biology of 
the CNS. In this chapter, clinically relevant viral infections of the CNS that cause meningitis 
or encephalitis in humans and the murine models used to study these infections will be 
discussed as well as the current understanding of the role of chemokines and chemokine 
receptors in host protection and/or in neuropathology. Because many viral infections of the 
CNS are rare and without animal models, we have chosen to discuss those for which 
chemokine studies exist and have shed light on important aspects of antiviral and 
immunopathologic responses.  A clearer understanding of how chemokines and chemokine 
receptors impact the inflammatory response to viral infections within the CNS will lead to 
the identity of targets that can potentially be manipulated for either host defense or 
recovery. 
2. Flaviviruses 
2.1 WNV 
Viruses of the family Flaviviridae consist of approximately 70 members, of which four, West 
Nile virus (WNV), St. Louis encephalitis virus (SLE), Japanese encephalitis virus (JEV) and 
Murray Valley encephalitis virus (MVE) comprise the neurotropic Japanese encephalitis (JE) 
serogroup (Mukhopadhyay et al., 2005). These viruses are primarily spread through 
arthropod vectors. For instance, West Nile Virus (WNV) is a neurotropic virus that exists in 
nature as a zoonosis and is transmitted by the Culex mosquito to humans and other 
vertebrates (Hayes & Gubler, 2006). Most humans infected with WNV are asymptomatic, 
yet approximately 20% may develop a minor flu-like illness, known as West Nile Fever 
(Mostashari et al., 2001). Less than 1% of these patients develop severe neurological 
complications, such as encephalitis, that may potentially be lethal (Petersen & Roehrig, 
2001). Increased age and defects in cell-mediated immunity are risk factors for developing 
WNV neuroinvasive disease (Campbell et al., 2002; Murray et al., 2008), which provides 
clues to mechanisms of viral clearance within the CNS. 
A mouse model of WNV has contributed to the understanding of the pathogenesis of WNV 
encephalitis. Typically, mice are infected intra-dermally with WNV where it is taken up by 
Langerhans dendritic cells and brought to draining lymph nodes where replication results 
in primary viremia (Johnston et al., 2000). The virus continues to replicate in the spleen, 
kidney, and epithelial tissues before it enters the CNS (Chung et al., 2007). After entering the 
CNS, through both retrograde axonal transport and hematogenous dissemination (Samuel & 
Diamond, 2005; Hunsperger & Roehrig, 2006), WNV typically infects the brain stem, 
hippocampal, and spinal cord neurons (Eldadah & Nathanson, 1967; Omalu et al., 2003; 
Shrestha et al., 2003; Fratkin et al., 2004). Following infection of the CNS, CD4+ and CD8+ T 
cells, as well as NK cells and infiltrating monocytes/macrophages accumulate in the CNS 
and localize primarily in the vicinity of WNV-infected neurons. To clear virus from infected 
brain tissues, T cells, particularly virus-specific CD8+ T cells, monocytes, macrophages and 
Ǆǅ T cells as well as key cytokines, IFN-Ǆ and TNF-α, are necessary and aid in the immune 
response during WNV infection of the brain. The murine model of WNV encephalitis 
exploits age-related differences in virologic control. While eight week-old mice exhibit 50-
70% survival due to both peripheral and CNS control of viral replication, five week-old 
animals exhibit only a 10-20% survival rate due to inadequate virologic control within the 
CNS (Diamond et al., 2003).  
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2.2 Role of chemokines in WNV-induced encephalitis 
The recruitment of effector cells into the infected regions of the CNS is crucial for host 
defense against WNV and successful viral clearance within this compartment. Increased 
expression of inflammatory chemokines and their receptors (including CCR1, CCR2, CCR5, 
CXCR3 and CX3CR1) have been detected in the WNV-infected brain of 8 week-old mice 
(Glass et al., 2005). One of the first chemokine receptors identified to have a clear functional 
role in the mouse model of WNV is CCR5. WNV infection of mice with targeted deletion of 
CCR5 results in a fatal outcome due to the loss of virologic control in the CNS. In addition, 
loss of CCR5 was associated with reduced infiltration of CD4+ and CD8+ T cells, NK cells 
and macrophages in the CNS of WNV-infected mice (Glass et al., 2005). Thus, CCR5-
depedent influx of leukocytes into the virally infected CNS is fundamental to viral clearance 
and recovery from WNV encephalitis.  
One of the most highly expressed chemokines in the CNS in response to WNV infection is 
CXCL10, which is known to recruit NK and activated T cells (Muller et al., 2010). CXCL10 is 
expressed relatively early in the course of neuroinvasion of WNV, primarily because WNV-
infected neurons are the source of this chemokine (Klein et al., 2005). In the mouse, CXCL10 
expression exhibits a caudal-to-rostral pattern of expression, first found within Purkinje and 
granule cell neurons of the cerebellum and then detected within neurons of the 
hippocampus, frontal cortex and olfactory bulb.  In mice with targeted deletion of CXCL10, 
the ability to control viral replication within the CNS is lost and mortality is enhanced (Klein 
et al., 2005). The receptor for CXCL10, CXCR3, is also strongly upregulated by WNV in the 
mouse model and CXCR3 knockout mice demonstrate a similar increased susceptibility to 
the virus (Zhang et al., 2008). The loss of the ability of neurons to express CXCL10 or the loss 
of CXCR3 resulted in decreased leukocyte trafficking, specifically CD4+ and CD8+ T cells, 
particularly within the cerebellum. Thus, WNV differentially induces CXCL10 within the 
brain, which results in the recruitment of effector T cells via the chemokine receptor CXCR3. 
These studies demonstrate the ability of resident cells of the CNS to generate antiviral 
immune responses in a region-specific manner. 
Of interest, CXCL10 has also been shown to induce apoptosis of CXCR3-expressing neurons 
(Sui et al., 2006). During WNV, elevated levels of CXCL10, however, promote lymphocyte 
entry and do not appear to simultaneously enhance neuronal death (Zhang et al., 2010). 
Using in vivo and in vitro systems, it was determined that WNV-infected neurons also 
express TNF-α, which leads to down-regulation of CXCR3 mRNA levels and loss of surface 
expression of CXCR3 on neurons. Neuronal loss of CXCR3 in the context of WNV-infection 
promoted bystander survival of uninfected neurons, suggesting an adaptive mechanism to 
prevent CXCL10-mediated neuronal damage in the face of viral infections that require the 
entry of antiviral lymphocytes.  
Monocytes also play an important role during CNS injury and infection as precursors to 
macrophages and microglial cells (Getts et al., 2008). The accumulation of monocytes in the 
CNS occurred following a lethal intranasal inoculation with a non-neurotropic strain of 
WNV. Following treatment with an anti-CCL2 antibody, infiltration of these cells was 
delayed and survival was prolonged, suggesting a CCR2-dependent, pathogenic role for 
monocytes in the brain in this model (Getts et al., 2008). In contrast, monocyte depletion in 
mice challenged intraperitoneally with a neurotropic strain of WNV resulted in increased 
mortality (Ben-Nathan et al., 1996), suggesting a protective role for these cells. The ligands 
for CCR2, CCL2 and CCL7, are induced following WNV infection in the CNS (Glass et al., 
2005; Lim et al., 2010) and in mice with targeted deletion of CCR2, increased mortality and 
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increased viral burden occurs (Lim et al., 2010). Monocytosis occurs following WNV 
infection in WT mice and peaks just before monocytes begin to traffic into the brain (Lim & 
Murphy, 2011). This appears to be dependent on CCR2 since the numbers of recruited CD4+ 
and CD8+ T cells and NK cells in the brain of CCR2 knockout mice following WNV infection 
are similar to wild-type mice, whereas, the accumulation of inflammatory monocytes in the 
CNS is severely deficient. Thus, monocytes may be beneficial or harmful depending on the 
infection model. 
Studies of WNV infection in five week-old WT mice, which exhibit a 10-20% survival rate, 
indicated that impaired viral clearance and survival may be partially due to lack of 
migration of antiviral CD8+ T cells into the CNS parenchyma. Normally, infiltrating T cells 
are retained in perivascular spaces through the interaction of CXCR4 with its ligand 
CXCL12, which is found along abluminal surfaces of the entire CNS vasculature 
(McCandless et al., 2006; McCandless et al., 2008). Following WNV infection in eight week-
old mice, CXCL12 levels decline by day two post-infection, allowing egress of antiviral T 
cells (Durrant, unpublished data). In contrast, five week-old mice do not exhibit down-
regulation of CXCL12 until eight days post-infection, which is associated with perivascular 
accumulation of CXCR4-expressing T cells and increasing numbers of WNV-infected 
neurons. These data suggest that developmental changes in regulation of CXCL12 
expression at the blood-brain barrier may contribute to antiviral immune responses. In 
support of a critical role for CXCL12 in limiting egress of virus-specific CD8+ T cells, 
administration of the specific CXCR4 antagonist, AMD3100, was associated with increased 
migration of effector T cells into the CNS and enhanced viral clearance (McCandless et al., 
2008). CXCR4 antagonism was also associated with a rapid decrease in immune cell 
trafficking as virologic control ensued, suggesting that an early increase in virus-specific 
immune cell trafficking that controls viral infection ultimately leads to a rapid dampening of 
inflammation that would otherwise have pathologic consequences.  
Taken altogether, these studies support a role for chemokines in the final positioning of 
effector cells that dictates outcome of immune responses in response to viral invasion within 
the CNS. Since resolution of CNS infection is often a balance between immune-mediated 
pathogen clearance and the deleterious effects of inflammation, studies utilizing the murine 
WNV encephalitis model suggest that if the appropriate cells reach critical regions at the 
appropriate time, virologic control may be accomplished and less severe disease occur.  
2.3 CCR5 in human WNV disease 
Studies of patients that carry a 32 base-pair deletion within the coding sequence of CCR5 
(CCR5Δ32) indicate that human CCR5 is important in WNV pathogenesis. A genotype-
phenotype association study of patients carrying CCR5Δ32, who lack functional CCR5, 
suggested that WNV-infected CCR5Δ32 homozygous individuals exhibit higher incidences 
of symptomatic infection. Ultimately, CCR5 deficiency resulted in 100% susceptibility to 
severe symptomatic disease (Glass et al., 2006). This genetic deficiency supports the 
observations in the WNV mouse model that functional CCR5 is critical for viral control and 
disease progression. 
2.4 JEV 
Japanese encephalitis virus (JEV) is a mosquito borne pathogen that occurs throughout most 
of Asia. JEV causes infection of the CNS with a high mortality rate (Parida et al., 2006). 
www.intechopen.com
 
Chemokines and Viral Infections of the CNS 
 
121 
Clinical manifestation of JEV include fever, headache, vomiting, altered consciousness, and 
severe meningo-encephalitis (Kumar et al., 1990). Children appear to be at greatest risk of 
infection in endemic areas for unknown reasons. Following entry into the host, JEV 
generates a rapid inflammatory response, which results in infiltration of neutrophils into the 
CNS. JEV is highly neurotropic, infecting neuronal rather than non-neuronal tissues in 
humans (Vaughn & Hoke, 1992) with neuronal precursors as the major target cells for 
infection (Kimura-Kuroda et al., 1993). The course of disease for JEV in humans is faithfully 
replicated in murine models. Following extraneural inoculation with JEV, young mice are 
highly susceptible to neuroinvasion and rapidly die soon after virus is detected within the 
CNS (Johnson et al., 1985; Hase et al., 1990). Thus, viral titers of JEV in the brain generally 
peak at five days post-infection with death occurring between five and six days post-
infection. 
2.5 Chemokines and JEV-associated encephalitis 
Expression of the chemokines CXCL10 and CXCL1 is upregulated in neuroblastoma cells 
infected with JEV (Gupta et al., 2010). In a JEV-infected mouse model, similar chemokines 
were significantly upregulated including CXCL9, CXCL10 and CXCL12 (Gupta et al., 2010). 
In addition to the robust expression of proinflammatory chemokines there was also 
increased numbers of infiltrating inflammatory cells into the brain at day five post-infection. 
Similar to WNV, JEV-infected neurons were found to be the source of CXCL10. CCL5 was 
also detected in JEV-infected neuroblastoma cells, indicating a possible role for this 
chemokine in the early stages of infection. Interestingly, neuronal death and mortality rate 
increases in patients with elevated levels of proinflammatory cytokines and chemokines, 
including CCL5, in the serum and cerebrospinal fluid (Winter et al., 2004). Whether this is 
simply correlative data or whether these chemokines actually contribute to pathogenesis is 
currently unknown. An improved understanding of the proinflammatory effects responsible 
for immune-mediated control of viral infection and neuronal injury during JEV infections is 
essential to determine the viral pathogenesis of JEV in the CNS.  
2.6 TBEV 
Tickborne encephalitis virus (TBEV) is an additional member of the Flaviviridae family that 
causes Tickborne encephalitis (TBE), a severe infection of the CNS. TBEV is usually 
transmitted to patients by infected Ixodes ricinus ticks (Gunther & Haglund, 2005). Infection 
with TBEV is characterized by a biphasic clinical course with early nonspecific influenza-like 
symptoms and subsequent development of neurological symptoms or meningoencephalitis 
(Haglund & Gunther, 2003; Holzmann, 2003). In most fatal cases, TBEV can be found in the 
brain tissue (Gelpi et al., 2005). An animal model for TBEV has not been established to date.  
The pro-inflammatory cytokines CCL2, CCL5, CXCL10 and CXCL11 have been detected in 
the CSF of TBE patients (Grygorczuk et al., 2006; Lepej et al., 2006; Michalowska-Wender et 
al., 2006). Although these chemokines exhibit known anti-viral roles in WNV encephalitis, 
their specific role in TBE is yet to be fully determined. One significant study, however, 
demonstrated an association between carriage of the CCR5Δ32 allele and TBE (Kindberg et 
al., 2008). Similar to WNV, an association between severe TBE and CCR5Δ32 homozygosity 
was observed. Therefore, loss of CCR5 function in humans is a risk factor for TBE in patients 
exposed to TBEV. Increased expression of CCL5 in the CSF of patients with TBE suggests it 
may indeed play a role in leukocyte trafficking within TBEV-infected patients. Thus, CCR5 
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may be essential for limiting viral replication within the CNS through effective antiviral 
immune responses that shorten the course and limit the lethality of encephalitis. 
3. HSV 
Herpes simplex virus (HSV) types 1 and 2 establish latent infection in dorsal root ganglia for 
the entire life of the host. From this reservoir they can reactivate to cause human morbidity 
and mortality. HSV-1 is the causative agent of encephalitis and several disorders of the 
peripheral nervous system. HSV-2 is responsible for meningitis in neonates and in adults 
(Steiner et al., 2007). HSV encephalitis is considered the most frequent cause of sporadic 
encephalitis in North America (Whitley, 1981). In a murine model of HSV-1 infection, the 
intracranial inoculation of a neurotropic HSV-1 strain causes encephalitis and death by day 
six after infection (Vilela et al., 2008). In a murine model of HSV-2 infection, intraperitoneal 
inoculation with a neurovirulent HSV-2 strain causes meningoencephalitis (Kristensson et 
al., 1978) and death occurs 10-14 days after infection. Pathology of HSV-2 infection has been 
shown to be T-cell mediated, due specifically to the actions of Th2 cells (Ikemoto et al., 1995).  
3.1 Chemokines and HSV 
Following intracranial inoculation of HSV-1, early chemokine expression is dominated by 
CCL2, CCL3, CCL5, CXCL9 and CXCL10 (Wickham et al., 2005; Carr et al., 2006). CCL2, in 
particular, exhibits an important role in the early immune response to CNS infection with 
HSV-1 as monocyte recruitment to the CNS is significantly diminished in mice with targeted 
deletion of CCL2, thus hindering viral clearance (Kodukula et al., 1999). CXCR3-deficient 
mice similarly exhibit elevated CNS viral titers of HSV-1, but only on day seven post-
infection. Interestingly, survival was enhanced in CXCR3-deficient mice compared with 
wild-type mice following HSV-1 infection (Wickham et al., 2005), suggesting a more 
complex role for CXCR3. Coinciding with increased viral titer, protein levels of CCL5, 
CXCL9, CXCL10 and IFN-Ǆ were increased in the CNS as well as CD8+ lymphocytes, 
suggesting a role for this receptor in antiviral adaptive immunity.  In the absence of CXCR3, 
a transient increase in viral burden facilitates an elevated protective immune response. 
In HSV-1-infected, CCR5-deficient mice, viral load was decreased in the CNS but associated 
with greater neuropathology and increased lethality (Teixeira et al., 2010). Following 
infection, CCR5-deficient mice exhibited increased chemokine levels, including CCL5 and 
CCL2; enhanced expression of cytokines, such as TNF-α; and a significant increase in 
leukocyte migration into the brain (Teixeira et al., 2010). Thus, in the absence of CCR5, 
greater control of viral replication was achieved, but at the cost of enhanced neuropathology 
and ultimately death. Generally, CCR5 deficiency would lead to decreased leukocyte 
infiltration; therefore, these results are surprising and may be unique to HSV-1 encephalitis. 
Treatment with anti-CCL5 antibodies or with small molecule antagonists of CCR1 and 
CCR5, both CCL5 receptors, had no effect on viral titers but led to significant reduction of 
the number of leukocytes infiltrating into the brain (Vilela et al., 2009). Therefore, blocking 
CCR1 and CCR5 did not affect HSV-1 replication, suggesting that other immune 
mechanisms are involved in the process of viral control.  
CCL2 has been identified as an initiator of Th2 responses and has a pathogenic role in the 
development of disease in HSV-2-infected mice (Karpus et al., 1997; Hogaboam et al., 1998). 
In the absence of CCL2 the severity of disease decreased dramatically, and the amount of 
Th2 cytokine production also decreased (Nakajima et al., 2001). It appears that a population 
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of macrophages in mouse CSF is the primary producers of CCL2, which are postulated to 
increase severity of disease through induction of Th2 responses. Of note, CCL2 has been 
detected in the CSF from patients with herpes simplex encephalitis and has been correlated 
with clinical severity of herpes simplex encephalitis (Rosler et al., 1998).  
4. LCMV 
Lymphocytic choriomeningitis virus (LCMV) is spread by the common house mouse and 
can cause aseptic meningitis in children and adults, neurological dysfunction in newborns 
and may induce spontaneous abortion in pregnant women (Enders et al., 1999). Infection 
with LCMV can present with two separate clinical phases. Symptoms of the first phase 
include fever, malaise, headache and nausea, which resolve after several days and are then 
followed by the second phase of illness, which is characterized by symptoms of meningitis 
(Bonthius, 2009) with an abundant number of lymphocytes within the CSF (Chesney et al., 
1979). Although recovery from CNS disease is common, severe neurological disease as well 
as death, although rare, may occur. Congenital infection with LCMV is often fatal for the 
fetus or newborn (Biggar et al., 1975). Survivors of congenital LCMV infection usually 
experience severe visual and cognitive impairment (Barton et al., 1995). LCMV infection of 
the brain parenchyma may extend specifically to neuronal precursor cells, especially in 
prenatal or neonatal infections (Bonthius et al., 2007). 
LCMV is essentially a noncytolytic virus (Hotchin & Weigand, 1961) and in murine models of 
LCMV-induced meningoencephalitis (LCM), intracranial infection of LCMV into healthy adult 
mice results in fatal meningitis between seven and ten days after viral infection (Cole et al., 
1972; Allan et al., 1987). Symptoms of disease are accompanied by a massive infiltration of 
mononuclear cells into the meninges, choroid plexus, CSF, and ependymal membranes 
(Doherty & Zinkernagel, 1974; Buchmeier et al., 1980; Ceredig et al., 1987; Doherty et al., 1990). 
CD8+ T cells and macrophages dominate the cellular infiltrate (Allan et al., 1987; Ceredig et al., 
1987), whereas CD4+ T cells and polymorphonuclear leukocytes are present in limited 
numbers (Ceredig et al., 1987; Dixon et al., 1987; Christensen et al., 1995). It appears that the T 
cell response is a critical component for LCM because lethal meningitis does not occur in 
immunodeficient (irradiated or T-cell-depleted) mice following intracranial infection (Doherty 
et al., 1974; Christoffersen et al., 1976). Moreover, in the absence of CD8+ T cells, mice will 
invariably survive intracranial LCMV infection (Christoffersen et al., 1976; Leist et al., 1987), 
suggesting that virus-specific CD8+ cytotoxic T lymphocytes mediate fatal tissue damage 
(Buchmeier et al., 1980; Doherty et al., 1990). The role of virus-specific CD8+ T cells during 
lethal LCM appears to be dependent on the strain of virus. Mice infected with the Armstrong 
strain of LCMV leads to killing of virus-infected cells in the meninges via a perforin-dependent 
mechanism (Kagi et al., 1994), which leads to increased immunopathology. Whereas, mice 
infected with the Traub strain of LCMV exhibit lymphocytic infiltration of the 
neuroparenchyma rather than meningeal inflammation, which leads to a more fatal outcome 
(Christensen et al., 2004). Overall, pathogenesis and death may be directly related to the influx 
of virus-specific T cells into critical regions of the CNS. 
4.1 Chemokines and Lymphocytic choriomeningitis 
During the mouse model of LCMV infection, expression of the T cell chemoattractants 
CCL2, CCL4, CCL5 and CCL7 as well as CXCL9, CXCL10 and CXCL11 is detected in the 
virus-infected tissues, as well as in the meninges, as early as day three post-infection 
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(Asensio & Campbell, 1997; Nansen et al., 2000; Nansen et al., 2002; Lindow et al., 2003). On 
days six to seven post-infection, expression of these chemokines is significantly increased 
and accompanied by increased expression of granulocyte chemoattractants including XCL1 
and CXCL2, CXCL6, CXCL16, and CCL3 (Asensio & Campbell, 1997; Nansen et al., 2000). 
The main chemokine-producing cell types are resident cells of the CNS, particularly the 
meninges and choroid plexus together with astrocytes (Loetscher et al., 2001). This surge of 
chemokine activity coincides with immune cell infiltration into the infected tissue. An 
analysis of chemokine receptor expression revealed local expression of receptors for these 
chemokines including CCR1, CCR2 and CCR5 as well as CXCR3 around day six to seven 
post-infection. (Nansen et al., 2000; Lindow et al., 2003). The analyses of cells from the 
inflammatory exudate of LCMV-infected mice indicate that T cells express CCR2, CCR5, and 
CXCR3, whereas macrophages are the predominant cell type expressing CCR1 (Nansen et 
al., 2000; Lindow et al., 2003; Christensen et al., 2004). Thus, the elevated expression of these 
chemokines and chemokine receptors is likely to result in T lymphocytic and macrophage 
infiltration to the inflammatory site. 
The chemokines CXCL9, CXCL10 and CXCL11 are the three known ligands for the receptor 
CXCR3 (Loetscher et al., 2001). CXCL10 is rapidly upregulated in the virus-infected CNS 
(Asensio et al., 1999; Nansen et al., 2000), which results in the recruitment of CXCR3+ cells 
into critical regions of the CNS. CXCL9 and CXCL11 are also expressed, but their role 
appears to be redundant (Christensen et al., 2006). The majority of cells found to be 
expressing CXCR3 were activated IFN-Ǆ-producing CD8+ T cells (Homann et al., 2001; 
Christensen et al., 2004). A strong positive feedback loop is established through the local 
production of IFN-Ǆ, which brings about further, marked upregulation of CXCL10 
expression and therefore continued recruitment of CXCR3+ effector cells. This robust 
recruitment positions CXCL10 as a key mediator of severe LCMV-induced CNS disease. In 
the absence of CXCL10, approximately half of LCMV (Traub) intracranially infected mice 
are protected from a lethal viral dose (Christensen et al., 2006). CXCL10-deficient mice show 
no impairment of effector T cell generation or of immune cell infiltration, except for reduced 
CD8+ T cell accumulation in parenchymal regions such as the corpus callosum (Christensen 
et al., 2006). On the other hand, CXCL10 appears to be dispensable for the development of 
fatal neuroinflammation following infection with LCMV (Armstrong) (Hofer et al., 2008). 
This highlights that there are underlying differences in viral strains and chemokine 
utilization with regards to disease outcome.  
The chemokine receptor CXCR3 is upregulated in LCMV-infected CNS (Lindow et al., 2003), 
and is predominately expressed on activated CD8+ T cells (Christensen et al., 2004). During 
intracranial infection with LCMV (Traub), CXCR3 deficiency leads to partial protection from 
immunopathology and death (Christensen et al., 2004). In immunocompetent mice infected 
with LCMV (Traub), CD8+ T cells preferentially traffic to the leptomeninges and choroid 
plexus and are also found in some parenchymal regions, such as the corpus callosum 
(Christensen et al., 2004). However, in the absence of CXCR3, trafficking of these cells to 
specific regions was significantly delayed (Christensen et al., 2004). This suggests that during 
LCMV infection, the expression of certain chemokines is necessary to target effector cells 
into infected CNS regions. However, this targeting, while important for viral control, may 
cause neuropathology. In addition, it is apparent that not only the recruitment of effector 
cells but the over-accumulation of the cells in infected regions of the CNS through the 
establishment of a CXCL10-mediated positive feedback loop may lead to immunopathology 
in these critical regions.  
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In addition to CXCR3, other chemokine receptors may also contribute to effector T cell 
recruitment, since in the absence of CXCR3 only partial protection is achieved. The 
expression of CCR1, CCR2, and CCR5, has also been associated with meningeal 
inflammation (Nansen et al., 2000). A subpopulation of activated CD8+ T cells expresses high 
levels of CCR2 and CCR5 (Andersson et al., 1995). Yet, when CCR5 expression is absent 
there is no impairment of the LCMV-induced inflammation (Nansen et al., 2002), supporting 
the notion that other chemokine receptors contribute to T cell recruitment. Overall, in 
addition to CXCR3, virus-activated CD8+ T cells were found to express CCR2 and CCR5, 
whereas activated macrophages expressed CCR1 (Nansen et al., 2000).  
LCM is essentially the result of anti-viral effector T cells unable to control rapid replication 
of LCMV in the brain. Following viral infection, a highly potent T cell response is induced. 
There is a rapid and robust infiltration of effector T cells into the meninges of the CNS, 
which leads to increased local expression of IFN-, which leads to increased chemokine 
production and amplification of effector T cell infiltration. Lack of effective viral clearance 
contributes to persistent chemokine expression, which promotes excessive inflammation 
within the meninges and eventually the brain parenchyma, leading to a fatal outcome. 
4.2 CXCL10/CXCR3 in human LCMV infection 
One characteristic of LCMV infection in immunocompetent adults and children is the 
abundance of lymphocytes in the CSF (Bonthius, 2009). CD8+ T cells are thought to infiltrate 
into the CSF to primarily clear the virus, which subsequently leads to the symptoms of 
aseptic meningitis during LCMV infection (Buchmeier & Lane, 1999). A predominant 
chemokine found in the CSF of patients with viral meningoencephalitis is CXCL10 (Lahrtz et 
al., 1997). CXCL10 and its receptor CXCR3 have integral roles in the development of 
neuropathology in the mouse model of LCMV infection and may also have similar roles in 
the LCMV-infected CNS of certain patients. The infiltration of effector T cells into the CSF, 
CXCL10 expression and the resulting neuropathy are reminiscent of the mouse model, 
however the host factors that contribute to disease severity and, in some cases, lethality are 
not currently understood. Overall, chemokines appear to be important in viral control but, 
as seen with murine models of LCMV, also contribute to neuropathology. 
5. HIV 
Human immunodeficiency virus-1 (HIV) targets CD4+ cells and macrophages. Infection of 
the CNS by HIV-1 occurs in about 80% of infected individuals. HIV-1 arrives in the CNS via 
infected macrophages that cross the blood-brain barrier. Neurological symptoms include 
meningitis, encephalitis, neuropathies, and HIV-1-associated dementia (HAD), with 
cognitive, motor, and behavioral dysfunctions (Marcotte et al., 2003). Chemokine 
involvement in HIV-1 neuropathogenesis is well recognized because of their roles in the 
recruitment of HIV-1 infected immune cells, inflammatory responses, and as ligands for the 
HIV-1 coreceptors, CXCR4 and CCR5, which are expressed by neurons and directly mediate 
neurotoxicity and cell death (Hesselgesser et al., 1998; Klein et al., 1999; Hosking & Lane, 
2010). 
Chemokines that recruit monocytes/macrophages and lymphocytes into the brain, such as 
CCL2, have been detected in the CSF of individuals with HIV-1 infection (Kolb et al., 1999). 
CCL2 levels are significantly increased during HIV-1-induced encephalitis (HIVE) and the 
chemokine accumulates in the CSF and brains of patients with HAD and HIVE, as well as in 
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macaques with Simian immunodeficiency virus (SIV)-induced encephalitis (SIVE) 
(Mankowski et al., 2004; Monteiro de Almeida et al., 2005; Monteiro de Almeida et al., 2006). 
The expression of CCL2 in the CNS is associated with enhanced progression of HIV 
encephalitis, due to its ability to recruit monocytes and lymphocytes (Dhillon et al., 2008). In 
addition to CCL2, CXCL10 also can attract inflammatory cells and has been detected in the 
CSF of HIV-1-infected patients (Kolb et al., 1999). CXCL10 is chronically expressed within 
the brains of patients suffering from HIV-associated neurological disorders (Christo et al., 
2009). In addition, HIV-1 envelope glycoprotein gp120 can induce CXCL10 gene expression 
in astrocytes independent of IFN-Ǆ (Asensio et al., 2001). The encephalitic brain from SIV-
infected animals exhibits elevated immunohistochemical expression of CCL3, CCL4, CCL5, 
CCL7 and CXCL10 (Sasseville et al., 1996), suggesting a role for one or multiple chemokines 
in the pathogenesis of acquired immune deficiency syndrome encephalitis. Elevated levels 
of CCL7, another ligand for CCR2, are also detected within activated astrocytes in the brains 
of SIV-infected macaques, and are increased further in response to TNF-, which thus 
initiates neuroinvasion by SIV/HIV-infected monocytes (Renner et al., 2011). The prevention 
of monocyte infiltration into the brains of HIV-infected patients is therefore a critical step in 
limiting the ability of the CNS to act as a viral reservoir.   
Chemokines may also act as neuromodulators within the HIV-infected CNS. The HIV 
glycoprotein gp120 may induce neuronal death via excitotoxicity during activation of 
CXCR4 receptors (Ohagen et al., 1999; Chen et al., 2002) and the CXCR4 ligand, CXCL12 may 
be converted into a neurotoxic agent via proteolytic cleavage with the resulting peptide 
capable of inducing neurotoxicity and apoptosis through engagement of the chemokine 
receptor CXCR3 (Vergote et al., 2006). Thus, in addition to attracting inflammatory cells that 
contribute to neuropathology, CXCL10 can also synergize with CXCL12 cleavage products 
to induce neuronal cell death (van Marle et al., 2004).  
6. Concluding remarks 
An effective anti-viral immune response is vital to maintain a balance between pathogen 
control and immunopathology during viral infection resolution within the CNS. While 
chemokines may contribute to viral clearance through focused amplification of 
inflammatory responses, they may also contribute to immune-mediated damage that 
depends on the type of virus and affected CNS compartment or region. However, targeting 
chemokines to abrogate all CNS infiltration may lead to untoward effects on 
immunosurveillance, as evidenced by the recent increase in opportunistic CNS viral 
infection with JC virus in patients treated with the anti-α4-integrin monoclonal antibody, 
natalizumab. Natalizumab treats multiple sclerosis, a chronic, inflammatory demyelinating 
disease, by preventing leukocyte entry at CNS endothelial barriers (Kleinschmidt-DeMasters 
& Tyler, 2005). A side effect of this treatment is the occurrence of progressive multifocal 
leukoencephalopathy (PML), a fatal opportunistic viral infection of the CNS caused by the 
reactivation of latent JC virus infection (Havrdova et al., 2009). Thus, blockade of immune 
cell trafficking into the CNS interferes with essential components of immune surveillance 
that prevent opportunistic infections. PML underscores how vital immune cell trafficking in 
the CNS is for monitoring and regulating immune responses. 
In summary, chemokines are integrally involved in recruiting targeted leukocyte 
populations to critical regions of the CNS that contribute both to host defense and the 
pathogenesis of disease. It is clear that these proinflammatory molecules exert 
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nonredundant roles in contributing to neuroinflammation following viral infection of the 
CNS thus meriting further studies on chemokines with regards to viral-induced disease. 
Finally, it is clear that chemokines and their receptors may represent viable targets in 
modulating the severity of human neuroinflammatory diseases. 
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